The following table sets forth the reconciliations of the numerators and denominators of the Company’s basic and diluted earnings (loss) per share calculations for the years ended December 31, 2024, 2023 and 2022.


	Year Ended December 31,
	2024		2023			2022
Numerator:
Net income (loss) attributable to Chemours	$	86	$	(238	)	$	578
Denominator:
Weighted-average number of common shares outstanding - basic		149,494,462		148,912,397			155,359,361
Dilutive effect of the Company’s employee compensation plans (1)		677,827		—			2,943,646
Weighted-average number of common shares outstanding - diluted		150,172,289		148,912,397			158,303,007

Basic earnings (loss) per share of common stock (2)	$	0.58	$	(1.60	)	$	3.72
Diluted earnings (loss) per share of common stock (1) (2)		0.57		(1.60	)		3.65

(1)

In periods where the Company incurs a net loss, the impact of potentially dilutive securities is excluded from the calculation of EPS, as their inclusion would have an anti-dilutive effect. As such, with respect to the measure of diluted EPS, the impact of 1,584,958 potentially dilutive securities is excluded from the calculation for the year ended December 31, 2023.

(2)

Figures may not recalculate exactly due to rounding. Basic and diluted earnings (loss) per share are calculated based on unrounded numbers.

The following table sets forth the average number of stock options and performance stock options that were out of the money and, therefore, were not included in the Company’s diluted earnings (loss) per share calculations for the years ended December 31, 2024, 2023 and 2022.


	Year Ended December 31,
	2024		2023		2022
Average number of stock options		2,246,602		1,444,099		1,077,922